EP2977057 - Bibliographic data
LIPASE ACIDE LYSOSOMALE N-GLYCOSYLÉE RECOMBINANTE HUMAINE
| Last update | 06/06/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Européen |
| (73) Holder |
ALEXION PHARMACEUTICALS, INC. 121 Seaport Boulevard
02210 s
BOSTON, MASSACHUSETTS
États-Unis d'Amérique
|
|---|---|
| (72) Inventors |
Anthony Quinn 107 Manet Road
Chestnut Hill, MA Massachusetts 02467
États-Unis d'Amérique
|
| (74) Agent |
Mail recipient Mathys & Squire The Shard
32 London Bridge Street
London SE1 9SG
Royaume-Uni
|
| (21) Request number | EP14200334.2 |
|---|---|
| (22) Request date | 09/09/2011 |
| (11) Publication number | EP2977057 |
|---|---|
| Publication date | 06/11/2019 |
| (54) Title of the invention | LIPASE ACIDE LYSOSOMALE N-GLYCOSYLÉE RECOMBINANTE HUMAINE |
|---|---|
| (51) International classification | C12N 9/18, A61K 38/46, A61K 31/135, A61K 31/366, A61K 31/397, A61K 31/465, A61P 3/06 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 403011 P |
|---|---|
| Initial application | None |
| Divisional application | EP19199414.4 /EP3650039 None |
| Expected annuity |
Annuity: 10 -
Amount: 170 € -
Due date 30/09/2020
Surtax: 10 - Amount: 34 € - Due date 01/04/2021 |
|---|---|
| Last annuity | None |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 06/11/2019 Entrée en période de grâce du brevet d'invention - Legal date 01/10/2020 Déchéance du brevet d'invention après période de grâce - Legal date 30/09/2020 |